PCa focal therapy: Who are the best candidates?

March 17, 2020

In this video, Scott Eggener, MD, outlines which patients are the best candidates for focal therapy for prostate cancer, and discusses the differences in follow-up for patients treated with focal therapy compared with those undergoing active surveillance.

In this video, Scott Eggener, MD, of the University of Chicago, outlines which patients are the best candidates for focal therapy for prostate cancer, and discusses the differences in follow-up for patients treated with focal therapy compared with those undergoing active surveillance.

 

More videos from Urology Times:

Study will test targeted PCa therapies based on genomic alterations

LUGPA President Dr. Richard Harris: 2020 challenges

Dr. Mara Holton discusses LUGPA's recent policy victories, upcoming challenges